Skip to main content
CERS filings

Corporate insider profile

Eric Bjerkholt Filing Activity

Latest reported as Director of CERUS CORP (CERS).

Purchase filings
0
Reported companies
2
Net open-market value
-$522,257.40
Latest transaction
Jun 9, 2026

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 9, 2026CERUS CORP (CERS)DirectorSale20,454$2.60$53,180
Jun 8, 2026Mirum Pharmaceuticals, Inc. (MIRM)CHIEF FINANCIAL OFFICERSale5,000$93.82$469,077